The Administrative Core (Core A) will serve as the administrative and operational hub of the Duke CFAR, providing oversight for all CFAR-related activities. Most importantly. Core A will work with the Department of Surgery, the academic home of the Duke CFAR, to provide overall financial management for the entire CFAR, and thereby maximize the impact of available CFAR funding on the establishment of critical infrastructure and an array of different support mechanisms in service to the community of HIV/AIDS researchers at Duke. This will include budget management of all CFAR Cores, matching fund allocation through the School of Medicine, and any other resources made available to the CFAR. The Core will work closely with the External and Internal Advisory Committees as well as the CFAR Executive Committee to fully implement all approved directives, programmatic changes and new initiatives, thus facilitating all aspects of the CFAR Strategic Planning process. Core A will organize all symposia, scientific retreats, yearly reviews, CFAR seminars, and strategic planning sessions, and will assist the Basic Science Director and the Developmental Core Director in conducting scientific peer review of the applications received in response to semi-annual Duke CFAR RFAs. The Administrative Core will promote comprehensive communication among the CFAR membership through the Duke CFAR website ( an e-mail listserve, and a quarterly newsletter, and will establish additional open lines of communication as the need arises. Finally, the Core will serve as the main point of contact between the Duke CFAR and NIH Program Staff, and the Core will be responsible for organizing and submitting all forms of written communication with the NIH, including annual Progress Reports, requests for supplemental funding, requests for investigator status changes, rebudgeting requests, and competitive renewal applications.

Public Health Relevance

The Duke CFAR will create critical infrastructure and provides a variety of important support mechanisms to basic and clinical investigators conducting HIV/AIDS research at Duke. Facilitation of these broad and highly intensive research efforts will accelerate the discovery of important new therapeutic modalities and vaccine strategies that will serve as future tools for treatment and prevention of HIV-1 infection and thedevastafing effects of AIDS.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-JBS-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Zhang, Helen L; Rhea, Sarah K; Hurt, Christopher B et al. (2018) HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers. J Acquir Immune Defic Syndr 77:72-77
Cichowitz, Cody; Mazuguni, Festo; Minja, Linda et al. (2018) Vulnerable at Each Step in the PMTCT Care Cascade: High Loss to Follow Up During Pregnancy and the Postpartum Period in Tanzania. AIDS Behav :
Tabb, Zachary J; Mmbaga, Blandina T; Gandhi, Monica et al. (2018) Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania. AIDS 32:1115-1123
Williams, Wilton B; Han, Qifeng; Haynes, Barton F (2018) Cross-reactivity of HIV vaccine responses and the microbiome. Curr Opin HIV AIDS 13:9-14
Cherenack, Emily M; Sikkema, Kathleen J; Watt, Melissa H et al. (2018) Avoidant Coping Mediates the Relationship Between Self-Efficacy for HIV Disclosure and Depression Symptoms Among Men Who Have Sex with Men Newly Diagnosed with HIV. AIDS Behav 22:3130-3140
Sikkema, Kathleen J; Mulawa, Marta I; Robertson, Corne et al. (2018) Improving AIDS Care After Trauma (ImpACT): Pilot Outcomes of a Coping intervention Among HIV-Infected Women with Sexual Trauma in South Africa. AIDS Behav 22:1039-1052
Blasi, Maria; Negri, Donatella; LaBranche, Celia et al. (2018) IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells. Commun Biol 1:134
Collins, Lauren F; Chan, Austin; Zheng, Jiayin et al. (2018) Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection. Open Forum Infect Dis 5:ofx264
Wills, Saintedym; Hwang, Kwan-Ki; Liu, Pinghuang et al. (2018) HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis. J Virol 92:
Watt, Melissa H; Knippler, Elizabeth T; Knettel, Brandon A et al. (2018) HIV Disclosure Among Pregnant Women Initiating ART in Cape Town, South Africa: Qualitative Perspectives During the Pregnancy and Postpartum Periods. AIDS Behav 22:3945-3956

Showing the most recent 10 out of 488 publications